Evidence map›Paper›PMID 40771969›Full record

ArticleFrontiers in neurology2025

The role of ASPECTS score, atrial fibrillation, and revascularization therapy in predicting hemorrhagic transformation of ischemic stroke: results from a prospective cohort study.

Elena Costru-Tasnic, Mihail Gavriliuc, Olesea Odainic, Mihai Tasnic, Elena Manole

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elena Costru-TasnicDiomid Gherman Institute of Neurology and Neurosurgery, Chisinau, Moldova.
Mihail GavriliucDiomid Gherman Institute of Neurology and Neurosurgery, Chisinau, Moldova.
Olesea OdainicDiomid Gherman Institute of Neurology and Neurosurgery, Chisinau, Moldova.
Mihai TasnicMedPark International Hospital, Chisinau, Moldova.
Elena ManoleNicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Moldova.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hemorrhagic transformation (HT) can seriously complicate and worsen the clinical outcome of acute ischemic stroke (AIS) patients. Atrial fibrillation (AF), larger stroke volumes, and reperfusion therapy are associated with increased risk for HT in AIS. The aim of our research was to evaluate the combined prognostic value of the ASPECTS score, AF, and revascularization therapy in predicting HT in AIS patients. Methods: A prospective observational study was conducted. Demographic data, presence of AF, application of revascularization therapy, and baseline ASPECTS were recorded. The primary outcome was the occurrence of HT during hospitalization. Univariate and multivariate logistic regression analyses were applied to identify potential predictors. ROC analysis was performed to assess the prognostic value of the analyzed parameters for HT prediction. Results: Data from 150 successive AIS patients was registered for the final analysis. The active group (with HT during hospitalization) included 55 patients. No significant differences in age, gender distribution, or time to admission between the HT and control groups, were recorded. Lower ASPECTS, presence of AF, and revascularization therapy were independently associated with an increased risk of HT ( Conclusion: Our findings suggest that ASPECTS score, AF, and revascularization therapy are important predictors of hemorrhagic transformation in AIS. These results support the use of a combined clinical-imaging approach for risk stratification of HT in acute ischemic stroke patients.

Indexed as

aspectsatrial fibrillationhemorrhagic transformationischemic stroke prognosisrevascularization therapy

Identifiers

PMID40771969
PMCPMC12325191

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.